Developing software for hospitals inventory.
Identi Healthcare enters 2026 with real gross-margin improvement and tighter expense control, but still without proof that it can turn that improvement into cash and stable commercialization.
Identi does not show financing independence in 2025. It shows a model in which equity issuance, controlling-shareholder parallel loans, and related-party operating layers fill the gap left by still-negative operating cash flow.
The U.S. orders already show that Identi has a real commercial opening in its target market, but not yet that this opening has become a repeatable growth engine. Mayo is the stronger signal because it already shows a sequence of prior engagement, first order, and follow-on pilot.
